William Pinon
Chief Executive Officer at Terumo Heart, Inc.
Profile
William M.
Pinon currently works at Terumo Heart, Inc., as President & Chief Executive Officer.
Mr. Pinon also formerly worked at U.S.
Stem Cell, Inc., as President & Chief Executive Officer from 2007 to 2008, Cardigant Medical, Inc., as Chairman from 2012 to 2014, Centocor, Inc., as Sales Executive Director-Cardiovascular Business from 2000 to 2002, Cordis Corp., as Vice President-Worldwide Sales & Marketing from 2006 to 2007, Biologics Delivery Systems, as VP-Cordis Business Unit & General Manager from 2005 to 2006, and Cordis Cardiology, as Vice President-Commercial Operations from 2003 to 2004.
Mr. Pinon received his undergraduate degree from the University of Oregon.
William Pinon active positions
| Companies | Position | Start |
|---|---|---|
| Terumo Heart, Inc. | Chief Executive Officer | - |
Former positions of William Pinon
| Companies | Position | End |
|---|---|---|
Cardigant Medical, Inc.
 Cardigant Medical, Inc. BiotechnologyHealth Technology Cardigant Medical, Inc. operates as a development stage biotechnology company. The company focuses on the development of novel biologic compounds and methods for local delivery for the treatment of cardiovascular and peripheral vascular disease. It plans to treat atherosclerosis and plaque stabilization using targeted delivery of large molecule therapeutics based on high density lipoprotein targets. The company also focuses on the use of biologics and combination biologics and devices for the treatment of acute coronary syndromes, carotid stenosis and aortic valve stenosis. Cardigant Medical was founded on April 17, 2009 by Jerett A. Creed and is headquartered in Manhattan Beach, CA. | Chairman | 2014-08-21 |
| U.S. STEM CELL, INC. | President | 2008-06-30 |
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Sales & Marketing | 2007-01-31 |
| Biologics Delivery Systems | Corporate Officer/Principal | 2006-03-31 |
Cordis Cardiology
 Cordis Cardiology Miscellaneous Commercial ServicesCommercial Services Part of Cardinal Health, Inc., Cordis Cardiology engages in development and manufacturing of interventional cardiovascular and endovascular technologies. The company is based in Miami Lakes, FL. The CEO of the company is Shar Matin. | Corporate Officer/Principal | 2004-11-30 |
Training of William Pinon
| University of Oregon | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| U.S. STEM CELL, INC. | Health Services |
| Private companies | 6 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
| Terumo Heart, Inc. | |
Cardigant Medical, Inc.
Cardigant Medical, Inc. BiotechnologyHealth Technology Cardigant Medical, Inc. operates as a development stage biotechnology company. The company focuses on the development of novel biologic compounds and methods for local delivery for the treatment of cardiovascular and peripheral vascular disease. It plans to treat atherosclerosis and plaque stabilization using targeted delivery of large molecule therapeutics based on high density lipoprotein targets. The company also focuses on the use of biologics and combination biologics and devices for the treatment of acute coronary syndromes, carotid stenosis and aortic valve stenosis. Cardigant Medical was founded on April 17, 2009 by Jerett A. Creed and is headquartered in Manhattan Beach, CA. | Health Technology |
| Biologics Delivery Systems | |
Cordis Cardiology
Cordis Cardiology Miscellaneous Commercial ServicesCommercial Services Part of Cardinal Health, Inc., Cordis Cardiology engages in development and manufacturing of interventional cardiovascular and endovascular technologies. The company is based in Miami Lakes, FL. The CEO of the company is Shar Matin. | Commercial Services |
- Stock Market
- Insiders
- William Pinon
